Position in PFE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,027,541
-$222,103 QoQ
Shares Held
42,672
-4.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#1,312
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Truvestments Capital LLC holds $19,966,308 across 13 Drug Manufacturers - General names. PFE ranks #6 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
26,544 | $6,741,379 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
60,684 | $3,496,612 | |
| 3 | MRK |
Merck & Co., Inc.
|
25,027 | $3,215,969 | |
| 4 | ABBV |
AbbVie Inc.
|
9,790 | $2,463,555 | |
| 5 | LLY |
ELI LILLY & Co
|
1,330 | $1,595,242 | |
| 6 | PFE |
Pfizer Inc
This page
|
42,672 | $1,027,541 | |
| 7 | AMGN |
Amgen Inc
|
2,481 | $898,419 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,234 | $282,243 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,027,541 | 42,672 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,249,644 | 44,503 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,092,686 | 43,883 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,201,076 | 47,138 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $413,558 | 17,061 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $425,205 | 16,780 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $398,719 | 15,029 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $432,334 | 14,939 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $362,452 | 12,954 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $361,083 | 13,012 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $381,899 | 13,265 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $457,546 | 13,794 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $505,633 | 13,785 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $561,938 | 13,773 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $725,404 | 14,157 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $618,328 | 14,130 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $740,206 | 14,118 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $714,788 | 13,807 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $809,929 | 13,716 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $624,075 | 14,510 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $565,744 | 14,447 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,180,554 | 32,585 | Shares | Other | 2021-05-18 | |
| 2020-12-31 | $789,868 | 21,458 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $699,427 | 19,058 | Shares | Other | 2020-11-13 | |
| 2020-06-30 | $689,545 | 21,087 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $650,220 | 19,921 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||